stella
beta
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC) — Stella
Recruiting
Back to SCLC, Limited Stage trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Guangdong Provincial People's Hospital, Guangzhou, Guangdong
View full record on ClinicalTrials.gov